Clinical Trials Directory

Trials / Unknown

UnknownNCT01116167

Polycystic Ovary Syndrome (PCOS): Effect Of Letrozole and Berberine

Letrozole and Berberine in Infertile PCOS Patients

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
660 (estimated)
Sponsor
Heilongjiang University of Chinese Medicine · Academic / Other
Sex
Female
Age
20 Years – 40 Years
Healthy volunteers
Not accepted

Summary

Polycystic ovary syndrome (PCOS) is a heterogeneous disorder affecting almost4%-7% of the female population of reproductive age. Its heterogeneity is characterized by a wide spectrum of features, including ovulatory dysfunction and infertility, hyperandrogenism, hyperinsulinemia, insulin resistance (IR), and progression to type 2 diabetes.Since the Ming Dynasty in China,PCOS has been defined as "phlegm and wetness"infertility in traditional Chinese medicine ,namely "metabolic infertility".Chinese herbs have been used to treat PCOS for thousands of years with good effects.Berberine has also been used for diabetic patients in traditional Chinese medicine for hundreds of years. Recent studies have reported its effects on hyperglycemia and dyslipidemia.The purpose of this study is to determine whether Letrozole combined with berberine are effective in the treatment of infertile PCOS patients.

Conditions

Interventions

TypeNameDescription
DRUGLetrozole -BerberineLetrozole 2.5 mg letrozole daily from day 5 of the menses for 5 days for month 1 to 3, 5.0 mg letrozole daily from day 5 of the menses for 5 days for month 4 to 6. Berberine 1.5g daily for 6 month.
DRUGLetrozoleLetrozole 2.5 mg letrozole daily from day 5 of the menses for 5 days for month 1 to 3, 5.0 mg letrozole daily from day 5 of the menses for 5 days for month 4 to 6. Berberine Placebo 5 tablet tds for 6 months
DRUGBerberineBerberine 1.5g daily for 6 month. Letrozole placebo 1 tablet daily from day 5 of the menses for 5 days for month 1 to 3, 2 tablets daily from day 5 of the menses for 5 days for month 4 to 6.

Timeline

Start date
2009-10-01
Primary completion
2013-12-01
Completion
2013-12-01
First posted
2010-05-04
Last updated
2013-05-20

Locations

18 sites across 1 country: China

Source: ClinicalTrials.gov record NCT01116167. Inclusion in this directory is not an endorsement.